Mycoplasma Testing Market Analysis By Product, By Technology (PCR, ELISA, Direct Assay, Microbial Culture Techniques), By Application (Cell Line, Virus, & End of Production Cells Testing), By End-use, And Segment Forecasts, 2014 - 2025

  • ID: 4209706
  • Report
  • Region: Global
  • 90 pages
  • Grand View Research
1 of 4

FEATURED COMPANIES

  • InvivoGen
  • Lonza Group Ltd.
  • Merck KGaA
  • Promo Cell GmbH
  • MORE
The global mycoplasma testing market is expected to reach a value of USD 1.4 billion by 2025. With growing R&D investments in the field of life sciences, the demand for mycoplasma testing products are anticipated to rise in the near future. Huge opportunities in the life sciences segment are spurring the market growth. Hence, a large amount of investment is being made in the biotechnology and pharmaceutical industries with rising level of healthcare spending across the globe. This is expected to trigger high growth of mycoplasma testing market.

Investment in R&D activities by pharmaceutical and biotechnology companies is increasingly being supported by the government. Researches involving drug discovery and development, receive funding from the governmental bodies to a great extent. Moreover, governmental initiatives in the form of awareness campaigns for chronic diseases such as cancer are also encouraging research-based activities. Thus, the aforementioned factors are expected to drive the market growth.

Mycoplasma contamination of cell culture is a growing concern for most of the research scientists for decades. Mycoplasma infection arises majorly from laboratory workers as human mycoplasma contamination occurs at a faster rate. In order to combat further contamination, mycoplasma tests are being conducted, which is expected to increase the demand of the related products.

Further Key Findings From the Study Suggest:

In 2016, kits & reagents dominated the market and is also expected to show highest CAGR over the forecast period owing to its wider application in mycoplasma tests

Amongst the technology segment, Polymerase Chain Reaction (PCR) held the largest share in 2016 owing to the delivery of fast & accurate results associated with this technology

Cell line testing is anticipated to exhibit highest CAGR over the forecast period due to the increasing risk of cell line contamination

In 2016, pharmaceutical and biotechnology companies accounted for the largest market share due to rising number of research activities in drug discovery and development

North America dominated the market in 2016 owing to rising healthcare spending levels and government funding for life science-related research

Some of the key players are Merck KGaA; Sigma-Aldrich Co.; Thermo Fisher Scientific; Lonza Group Ltd.; Charles River Laboratories International, Inc.; PromoCell GmbH; and Bionique Testing Laboratories, Inc.
PLEASE NOTE: This report will be completed after order and will take approximately 1-2 business days after the confirmation of payment.
READ MORE
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • InvivoGen
  • Lonza Group Ltd.
  • Merck KGaA
  • Promo Cell GmbH
  • MORE
1 Research Methodology
1.1 Country Wise Market: Base Estimates
1.2 Global Market: CAGR Calculation
1.3 Region Based Segment Share Calculation
1.4 Research Scope & Assumptions
1.5 List of Data Sources
1.5.1 Data for primary interviews, by sources
1.5.2 Data for primary interviews, by region

2 Executive Summary
2.1 Market Snapshot

3 Mycoplasma Testing Market Variables, Trends & Scope
3.1 Market Segmentation & Scope
3.2 Market Driver Analysis
3.2.1 Increasing R&D investments in life sciences
3.2.2 Rising government support towards pharmaceutical and biotechnology industries
3.2.3 Rising cell culture contamination
3.3 Market Restraint Analysis
3.3.1 High cost of research in cell biology
3.4 Key Opportunities Prioritized
3.4.1 Key opportunities prioritized, by product
3.4.2 Key opportunities prioritized, by technology
3.4.3 Key opportunities prioritized, by application
3.4.4 Key opportunities prioritized, by end-use
3.5 Mycoplasma Testing - SWOT Analysis, By Factor (Political & Legal, Economic And Technological)
3.6 Industry Analysis - Porter’s
3.7 Competitive Landscape: Market Position Analysis, 2016

4 Mycoplasma Testing: Product Estimates & Trend Analysis
4.1 Mycoplasma Testing Market: Product Movement Analysis
4.2 Instruments
4.2.1 Instruments market estimate & forecast, 2014 - 2025 (USD Million)
4.3 Kits & Reagents
4.3.1 Kits & reagents market estimate & forecast, 2014 - 2025 (USD Million)
4.3.2 PCR Assays
4.3.2.1 PCR assays market estimate & forecast, 2014 - 2025 (USD Million)
4.3.3 Nucleic Acid Detection Kits
4.3.3.1 Nucleic acid detection kits market estimate & forecast, 2014 - 2025 (USD Million)
4.3.4 Stains
4.3.4.1 Stains market estimate & forecast, 2014 - 2025 (USD Million)
4.3.5 Standards & Controls
4.3.5.1 Standards & controls market estimate & forecast, 2014 - 2025 (USD Million)
4.3.6 Others
4.3.6.1 Others market estimate & forecast, 2014 - 2025 (USD Million)
4.4 Services
4.4.1 Services market estimate & forecast, 2014 - 2025 (USD Million)

5 Mycoplasma Testing: Technology Estimates & Trend Analysis
5.1 Mycoplasma Testing market: Technology movement analysis
5.2 PCR
5.2.1 PCR market estimate & forecast, 2014 - 2025 (USD Million)
5.3 ELISA
5.3.1 ELISA market estimate & forecast, 2014 - 2025 (USD Million)
5.4 Direct Assay
5.4.1 Direct assay market estimate & forecast, 2014 - 2025 (USD Million)
5.5 Indirect Assay
5.5.1 Indirect assay market estimate & forecast, 2014 - 2025 (USD Million)
5.6 Microbial Culture Techniques
5.6.1 Microbial culture techniques market estimate & forecast, 2014 - 2025 (USD Million)
5.7 Enzymatic Methods
5.7.1 Enzymatic methods market estimate & forecast, 2014 - 2025 (USD Million)

6 Mycoplasma Testing: Application Estimates & Trend Analysis
6.1 Mycoplasma Testing Market: Application Movement Analysis
6.2 Cell Line Testing
6.2.1 Cell line testing market estimate & forecast, 2014 - 2025 (USD Million)
6.3 Virus Testing
6.3.1 Virus testing market estimate & forecast, 2014 - 2025 (USD Million)
6.4 End of Production Cells Testing
6.4.1 End of production cells testing market estimate & forecast, 2014 - 2025 (USD Million)
6.5 Others
6.5.1 Others market estimate & forecast, 2014 - 2025 (USD Million)

7 Mycoplasma Testing: End-Use Estimates & Trend Analysis
7.1 Mycoplasma Testing Market: End-Use Movement Analysis
7.2 Academic Research Institutes
7.2.1 Academic research institutes market estimate & forecast, 2014 - 2025 (USD Million)
7.3 Cell Banks
7.3.1 Cell banks market estimate & forecast, 2014 - 2025 (USD Million)
7.4 Contract Research Organizations
7.4.1 Contract research organizations market estimate & forecast, 2014 - 2025 (USD Million)
7.5 Pharmaceutical & Biotechnology Companies
7.5.1 Pharmaceutical & biotechnology companies market estimate & forecast, 2014 - 2025 (USD Million)
7.6 Others
7.6.1 Others market estimate & forecast, 2014 - 2025 (USD Million)

8 Mycoplasma Testing Market: Regional Estimates & Trend Analysis, by Product, Technology, Application, End-Use
8.1 Mycoplasma testing market share by region, 2017 & 2025
8.2 North America
8.2.1 U.S.
8.2.1.1 U.S. mycoplasma testing market, by product, 2014 - 2025 (USD Million)
8.2.1.2 U.S. mycoplasma testing market, by technology, 2014 - 2025 (USD Million)
8.2.1.3 U.S. mycoplasma testing market, by application, 2014 - 2025 (USD Million)
8.2.1.4 U.S. mycoplasma testing market, by end-use, 2014 - 2025 (USD Million)
8.2.2 Canada
8.2.2.1 Canada mycoplasma testing market, by product, 2014 - 2025 (USD Million)
8.2.2.2 Canada mycoplasma testing market, by technology, 2014 - 2025 (USD Million)
8.2.2.3 Canada mycoplasma testing market, by application, 2014 - 2025 (USD Million)
8.2.2.4 Canada mycoplasma testing market, by end-use, 2014 - 2025 (USD Million)
8.3 Europe
8.3.1 Germany
8.3.1.1 Germany mycoplasma testing market, by product, 2014 - 2025 (USD Million)
8.3.1.2 Germany mycoplasma testing market, by technology, 2014 - 2025 (USD Million)
8.3.1.3 Germany mycoplasma testing market, by application, 2014 - 2025 (USD Million)
8.3.1.4 Germany mycoplasma testing market, by end-use, 2014 - 2025 (USD Million)
8.3.2 UK
8.3.2.1 UK mycoplasma testing market, by product, 2014 - 2025 (USD Million)
8.3.2.2 UK mycoplasma testing market, by technology, 2014 - 2025 (USD Million)
8.3.2.3 UK mycoplasma testing market, by application, 2014 - 2025 (USD Million)
8.3.2.4 UK mycoplasma testing market, by end-use, 2014 - 2025 (USD Million)
8.4 Asia Pacific
8.4.1 Japan
8.4.1.1 Japan mycoplasma testing market, by product, 2014 - 2025 (USD Million)
8.4.1.2 Japan mycoplasma testing market, by technology, 2014 - 2025 (USD Million)
8.4.1.3 Japan mycoplasma testing market, by application, 2014 - 2025 (USD Million)
8.4.1.4 Japan mycoplasma testing market, by end-use, 2014 - 2025 (USD Million)
8.4.2 China
8.4.2.1 China mycoplasma testing market, by product, 2014 - 2025 (USD Million)
8.4.2.2 China mycoplasma testing market, by technology, 2014 - 2025 (USD Million)
8.4.2.3 China mycoplasma testing market, by application, 2014 - 2025 (USD Million)
8.4.2.4 China mycoplasma testing market, by end-use, 2014 - 2025 (USD Million)
8.4.3 India
8.4.3.1 India mycoplasma testing market, by product, 2014 - 2025 (USD Million)
8.4.3.2 India mycoplasma testing market, by technology, 2014 - 2025 (USD Million)
8.4.3.3 India mycoplasma testing market, by application, 2014 - 2025 (USD Million)
8.4.3.4 India mycoplasma testing market, by end-use, 2014 - 2025 (USD Million)
8.5 Latin America
8.5.1 Brazil
8.5.1.1 Brazil mycoplasma testing market, by product, 2014 - 2025 (USD Million)
8.5.1.2 Brazil mycoplasma testing market, by technology, 2014 - 2025 (USD Million)
8.5.1.3 Brazil mycoplasma testing market, by application, 2014 - 2025 (USD Million)
8.5.1.4 Brazil mycoplasma testing market, by end-use, 2014 - 2025 (USD Million)
8.5.2 Mexico
8.5.2.1 Mexico mycoplasma testing market, by product, 2014 - 2025 (USD Million)
8.5.2.2 Mexico mycoplasma testing market, by technology, 2014 - 2025 (USD Million)
8.5.2.3 Mexico mycoplasma testing market, by application, 2014 - 2025 (USD Million)
8.5.2.4 Mexico mycoplasma testing market, by end-use, 2014 - 2025 (USD Million)
8.6 MEA
8.6.1 South Africa
8.6.1.1 South Africa mycoplasma testing market, by product, 2014 - 2025 (USD Million)
8.6.1.2 South Africa mycoplasma testing market, by technology, 2014 - 2025 (USD Million)
8.6.1.3 South Africa mycoplasma testing market, by application, 2014 - 2025 (USD Million)
8.6.1.4 South Africa mycoplasma testing market, by end-use, 2014 - 2025 (USD Million)

9 Competitive Landscape
9.1 Company Profiles
9.1.1 Thermo Fisher Scientific, Inc.
9.1.1.1 Company overview
9.1.1.2 Financial performance
9.1.1.3 Product benchmarking
9.1.1.4 Strategic initiatives
9.1.2 Merck KGaA
9.1.2.1 Company overview
9.1.2.2 Financial performance
9.1.2.3 Product benchmarking
9.1.2.4 Strategic initiatives
9.1.3 Lonza Group Ltd.
9.1.3.1 Company overview
9.1.3.2 inancial performance
9.1.3.3 Product benchmarking
9.1.3.4 Strategic initiatives
9.1.4 Promo Cell GmbH
9.1.4.1 Company overview
9.1.4.2 Financial performance
9.1.4.3 Product benchmarking
9.1.4.4 Strategic initiatives
9.1.5 American Type Culture Collection
9.1.5.1 Company overview
9.1.5.2 Financial performance
9.1.5.3 Product benchmarking
9.1.5.4 Strategic initiatives
9.1.6 Charles River Laboratories International, Inc.
9.1.6.1 Company overview
9.1.6.2 Financial performance
9.1.6.3 Product benchmarking
9.1.6.4 Strategic initiatives
9.1.7 Bionique Testing Laboratories, Inc.
9.1.7.1 Company overview
9.1.7.2 Financial performance
9.1.7.3 Product benchmarking
9.1.7.4 Strategic initiatives
9.1.8 Biological Industries Israel Beit Haemek Ltd.
9.1.8.1 Company overview
9.1.8.2 inancial performance
9.1.8.3 Product benchmarking
9.1.8.4 Strategic initiatives
9.1.9 InvivoGen
9.1.9.1 Company overview
9.1.9.2 Financial performance
9.1.9.3 Product benchmarking
9.1.9.4 Strategic initiatives

List of Tables

Table 1 Factors used in segment share estimation
Table 2 List of secondary data sources
Table 3 Primary interview details, by source
Table 4 Primary interview details, by region
Table 5 North America mycoplasma testing market, by country, 2014 - 2025 (USD Million)
Table 6 North America mycoplasma testing market, by product, 2014 - 2025 (USD Million)
Table 7 North America kits & reagents market, by type, 2014 - 2025 (USD Million)
Table 8 North America mycoplasma testing market, by technology, 2014 - 2025 (USD Million)
Table 9 North America mycoplasma testing market, by application, 2014 - 2025 (USD Million)
Table 10 North America mycoplasma testing market, by end-use, 2014 - 2025 (USD Million)
Table 11 U.S. mycoplasma testing market, by product, 2014 - 2025 (USD Million)
Table 12 U.S. kits & reagents market, by type, 2014 - 2025 (USD Million)
Table 13 U.S. mycoplasma testing market, by technology, 2014 - 2025 (USD Million)
Table 14 U.S. mycoplasma testing market, by application, 2014 - 2025 (USD Million)
Table 15 U.S. mycoplasma testing market, by end-use, 2014 - 2025 (USD Million)
Table 16 Canada mycoplasma testing market, by product, 2014 - 2025 (USD Million)
Table 17 Canada kits & reagents market, by type, 2014 - 2025 (USD Million)
Table 18 Canada mycoplasma testing market, by technology, 2014 - 2025 (USD Million)
Table 19 Canada mycoplasma testing market, by application, 2014 - 2025 (USD Million)
Table 20 Canada mycoplasma testing market, by end-use, 2014 - 2025 (USD Million)
Table 21 Europe mycoplasma testing market, by country, 2014 - 2025 (USD Million)
Table 22 Europe mycoplasma testing market, by product, 2014 - 2025 (USD Million)
Table 23 Europe kits & reagents market, by type, 2014 - 2025 (USD Million)
Table 24 Europe mycoplasma testing market, by technology, 2014 - 2025 (USD Million)
Table 25 Europe mycoplasma testing market, by application, 2014 - 2025 (USD Million)
Table 26 Europe mycoplasma testing market, by end-use, 2014 - 2025 (USD Million)
Table 27 Germany mycoplasma testing market, by product, 2014 - 2025 (USD Million)
Table 28 Germany kits & reagents market, by type, 2014 - 2025 (USD Million)
Table 29 Germany mycoplasma testing market, by technology, 2014 - 2025 (USD Million)
Table 30 Germany mycoplasma testing market, by application, 2014 - 2025 (USD Million)
Table 31 Germany mycoplasma testing market, by end-use, 2014 - 2025 (USD Million)
Table 32 UK mycoplasma testing market, by product, 2014 - 2025 (USD Million)
Table 33 UK kits & reagents market, by type, 2014 - 2025 (USD Million)
Table 34 UK mycoplasma testing market, by technology, 2014 - 2025 (USD Million)
Table 35 UK mycoplasma testing market, by application, 2014 - 2025 (USD Million)
Table 36 UK mycoplasma testing market, by end-use, 2014 - 2025 (USD Million)
Table 37 Asia Pacific mycoplasma testing market, by country, 2014 - 2025 (USD Million)
Table 38 Asia Pacific mycoplasma testing market, by product, 2014 - 2025 (USD Million)
Table 39 Asia Pacific kits & reagents market, by type, 2014 - 2025 (USD Million)
Table 40 Asia Pacific mycoplasma testing market, by technology, 2014 - 2025 (USD Million)
Table 41 Asia Pacific mycoplasma testing market, by application, 2014 - 2025 (USD Million)
Table 42 Asia Pacific mycoplasma testing market, by end-use, 2014 - 2025 (USD Million)
Table 43 Japan mycoplasma testing market, by product, 2014 - 2025 (USD Million)
Table 44 Japan kits & reagents market, by type, 2014 - 2025 (USD Million)
Table 45 Japan mycoplasma testing market, by technology, 2014 - 2025 (USD Million)
Table 46 Japan mycoplasma testing market, by application, 2014 - 2025 (USD Million)
Table 47 Japan mycoplasma testing market, by end-use, 2014 - 2025 (USD Million)
Table 48 China mycoplasma testing market, by product, 2014 - 2025 (USD Million)
Table 49 China kits & reagents market, by type, 2014 - 2025 (USD Million)
Table 50 China mycoplasma testing market, by technology, 2014 - 2025 (USD Million)
Table 51 China mycoplasma testing market, by application, 2014 - 2025 (USD Million)
Table 52 China mycoplasma testing market, by end-use, 2014 - 2025 (USD Million)
Table 53 India mycoplasma testing market, by product, 2014 - 2025 (USD Million)
Table 54 India kits & reagents market, by type, 2014 - 2025 (USD Million)
Table 55 India mycoplasma testing market, by technology, 2014 - 2025 (USD Million)
Table 56 India mycoplasma testing market, by application, 2014 - 2025 (USD Million)
Table 57 India mycoplasma testing market, by end-use, 2014 - 2025 (USD Million)
Table 58 Latin America mycoplasma testing market, by country, 2014 - 2025 (USD Million)
Table 59 Latin America mycoplasma testing market, by product, 2014 - 2025 (USD Million)
Table 60 Latin America kits & reagents market, by type, 2014 - 2025 (USD Million)
Table 61 Latin America mycoplasma testing market, by technology, 2014 - 2025 (USD Million)
Table 62 Latin America mycoplasma testing market, by application, 2014 - 2025 (USD Million)
Table 63 Latin America mycoplasma testing market, by end-use, 2014 - 2025 (USD Million)
Table 64 Brazil mycoplasma testing market, by product, 2014 - 2025 (USD Million)
Table 65 Brazil kits & reagents market, by type, 2014 - 2025 (USD Million)
Table 66 Brazil mycoplasma testing market, by technology, 2014 - 2025 (USD Million)
Table 67 Brazil mycoplasma testing market, by application, 2014 - 2025 (USD Million)
Table 68 Brazil mycoplasma testing market, by end-use, 2014 - 2025 (USD Million)
Table 69 Mexico mycoplasma testing market, by product, 2014 - 2025 (USD Million)
Table 70 Mexico kits & reagents market, by type, 2014 - 2025 (USD Million)
Table 71 Mexico mycoplasma testing market, by technology, 2014 - 2025 (USD Million)
Table 72 Mexico mycoplasma testing market, by application, 2014 - 2025 (USD Million)
Table 73 Mexico mycoplasma testing market, by end-use, 2014 - 2025 (USD Million)
Table 74 MEA mycoplasma testing market, by country, 2014 - 2025 (USD Million)
Table 75 MEA mycoplasma testing market, by product, 2014 - 2025 (USD Million)
Table 76 MEA kits & reagents market, by type, 2014 - 2025 (USD Million)
Table 77 MEA mycoplasma testing market, by technology, 2014 - 2025 (USD Million)
Table 78 MEA mycoplasma testing market, by application, 2014 - 2025 (USD Million)
Table 79 MEA mycoplasma testing market, by end-use, 2014 - 2025 (USD Million)
Table 80 South Africa mycoplasma testing market, by product, 2014 - 2025 (USD Million)
Table 81 South Africa kits & reagents market, by type, 2014 - 2025 (USD Million)
Table 82 South Africa mycoplasma testing market, by technology, 2014 - 2025 (USD Million)
Table 83 South Africa mycoplasma testing market, by application, 2014 - 2025 (USD Million)
Table 84 South Africa mycoplasma testing market, by end-use, 2014 - 2025 (USD Million)

List of Figures

Figure 1 Primary interviews, by sources
Figure 2 Primary interviews, by region
Figure 3 Market summary
Figure 4 Market trends & outlook
Figure 5 Market segmentation & scope
Figure 6 Market driver relevance analysis (Current & future impact)
Figure 7 Key opportunities prioritized, by product
Figure 8 Key opportunities prioritized, by technology
Figure 9 Key opportunities prioritized, by application
Figure 10 Key opportunities prioritized, by end-use
Figure 11 SWOT analysis, by factor (political & legal, economic and technological)
Figure 12 Porter’s five forces analysis
Figure 13 Mycoplasma testing market: Heat map analysis, 2016
Figure 14 Mycoplasma testing market product outlook: Key takeaways
Figure 15 Mycoplasma testing market: Product movement analysis
Figure 16 Instruments market estimate & forecast, 2014 - 2025 (USD Million)
Figure 17 Kits & reagents market estimate & forecast, 2014 - 2025 (USD Million)
Figure 18 PCR assays market estimate & forecast, 2014 - 2025 (USD Million)
Figure 19 Nucleic acid detection kits market estimate & forecast, 2014 - 2025 (USD Million)
Figure 20 Stains market estimate & forecast, 2014 - 2025 (USD Million)
Figure 21 Standards & controls market estimate & forecast, 2014 - 2025 (USD Million)
Figure 22 Others market estimate & forecast, 2014 - 2025 (USD Million)
Figure 23 Services market estimate & forecast, 2014 - 2025 (USD Million)
Figure 24 Mycoplasma testing market technology outlook: Key takeaways
Figure 25 Mycoplasma testing market: Technology movement analysis
Figure 26 PCR market estimate & forecast, 2014 - 2025 (USD Million)
Figure 27 ELISA market estimate & forecast, 2014 - 2025 (USD Million)
Figure 28 Direct assay market estimate & forecast, 2014 - 2025 (USD Million)
Figure 29 Indirect assay market estimate & forecast, 2014 - 2025 (USD Million)
Figure 30 Microbial culture techniques market estimate & forecast, 2014 - 2025 (USD Million)
Figure 31 Enzymatic methods market estimate & forecast, 2014 - 2025 (USD Million)
Figure 32 Mycoplasma testing market application outlook: Key takeaways
Figure 33 Mycoplasma testing market: Application movement analysis
Figure 34 Cell line testing market estimate & forecast, 2014 - 2025 (USD Million)
Figure 35 Virus testing market estimate & forecast, 2014 - 2025 (USD Million)
Figure 36 End of production cells testing market estimate & forecast, 2014 - 2025 (USD Million)
Figure 37 Others market estimate & forecast, 2014 - 2025 (USD Million)
Figure 38 Mycoplasma testing market end-use outlook: Key takeaways
Figure 39 Mycoplasma testing market: End-use movement analysis
Figure 40 Academic research institutes market estimate & forecast, 2014 - 2025 (USD Million)
Figure 41 Cell banks market estimate & forecast, 2014 - 2025 (USD Million)
Figure 42 Contract research organizations market estimate & forecast, 2014 - 2025 (USD Million)
Figure 43 Pharmaceutical & biotechnology companies market estimate & forecast, 2014 - 2025 (USD Million)
Figure 44 Others market estimate & forecast, 2014 - 2025 (USD Million)
Figure 45 Regional market place: Key takeaways
Figure 46 Regional outlook, 2017 & 2025
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
  • Thermo Fisher Scientific, Inc.
  • Merck KGaA
  • Lonza Group Ltd.
  • Promo Cell GmbH
  • American Type Culture Collection
  • Charles River Laboratories International, Inc.
  • Bionique Testing Laboratories, Inc.
  • Biological Industries Israel Beit Haemek Ltd.
  • InvivoGen
Note: Product cover images may vary from those shown
5 of 4
Note: Product cover images may vary from those shown
Adroll
adroll